Characterization of bacterial isolates collected from a sheep model of osseointegration.
Percutaneous osseointegrated implant technology provides a potential alternative to current socket prosthetics for individuals with limb loss. However, similar to other percutaneous devices, there remain concerns of periprosthetic infection. To understand this process of infection, bacterial isolates were collected and characterized from a sheep model of osseointegration. CSA-13, a novel cationic steroid antimicrobial, was used at the skin/implant interface in an attempt to reduce the rate of infection. Results indicated that in this application, normal flora and environmental organisms continued to colonize the skin/implant interface as well as cause infection in the presence of CSA-13. Two factors are believed to have contributed to this outcome: the delivery of CSA-13 and the lack of a skin seal at the skin/implant interface, which would create a biological barrier to infection.
Williams
Dustin L
DL
Associated Regional and University Pathologists (ARUP) Laboratories, ARUP Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108, USA. dustin.williams@utah.edu
Bloebaum
Roy D
RD
Beck
James P
JP
Petti
Cathy A
CA
D000818:Animals; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000494:pharmacology; D001419:Bacteria / Q000145:classification* / Q000302:isolation & purification*; D004195:Disease Models, Animal; D005260:Female; D008826:Microbial Sensitivity Tests; D016348:Osseointegration; D016459:Prosthesis-Related Infections / Q000382:microbiology* / Q000517:prevention & control*; D012756:Sheep; D013256:Steroids / Q000008:administration & dosage; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D013256:Steroids; C521528:ceragenin CSA-13
J Anat. 2006 Jul;209(1):59-67
16822270
Antimicrob Agents Chemother. 2008 Aug;52(8):2890-7
18490507
J Bone Joint Surg Br. 2008 Jan;90(1):114-21
18160512
Lancet. 1999 Jan 2;353(9146):51-6
10023965
Scand J Plast Reconstr Surg. 1982;16(1):17-21
7112035
Biomaterials. 2006 Aug;27(23):4183-91
16618500
Clin Infect Dis. 2008 Jul 1;47(1):73-82
18484878
J Biomed Mater Res A. 2008 May;85(2):366-70
17688277
J Periodontol. 2008 May;79(5):836-44
18454662
Arch Surg. 1998 Nov;133(11):1241-6
9820357
Biomaterials. 1997 Jul;18(14):969-78
9212192
Clin Infect Dis. 1998 Jun;26(6):1341-5
9636860
J Rehabil Res Dev. 2001 Mar-Apr;38(2):175-81
11392650
Transpl Infect Dis. 2007 Jun;9(2):114-20
17461996